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Abstract
Background: Attention deficit hyperactivity disorder (ADHD) is recognized as the most common, and most studied,
developmental age disorder. Basic information, such as the most appropriate case definition and the best way to
evaluate the disorder’s prevalence rate, however, remains an open issue.
Methods: A comprehensive meta-analysis on the epidemiology of ADHD in Italy, which was lacking from the
literature, was therefore performed to attempt to estimate the actual prevalence rate of ADHD, highlighting conceptual
and quantitative differences between clinical-diagnosis and survey-based symptoms studies. The Medline, Embase, and
PsycINFO databases, and the grey literature, were searched up to January 2018. The review was laid out in three main
sections: an overall prevalence estimate, an epidemiological profile of ADHD symptoms, and an attempt to define the
actual rate of ADHD diagnosis, as emerged from Italian studies.
Results: A total of 15 unique studies were included. These contributed to estimating the prevalence of ADHD in 67,838
subjects aged 5–17, representing 9 of the 20 regions (45%) of Italy. Overall, the pooled prevalence of ADHD was 2.9%
(range: 1.1–16.7%). When distinguishing studies based on case definition, however, we found an average prevalence
estimate, based on symptoms criteria, of 5.9% (range: 1.4 to 16.7%) and a best-estimate prevalence rate of 1.4% (range: 1.1
to 3.1%).
Conclusions: Following the case definition for epidemiological studies of ADHD, counting only subjects with an ADHD
diagnosis performed and confirmed by clinical assessment would reduce the wide variability in prevalence estimates, and,
above all, would both describe the real rate of subjects suffering from ADHD disorder and avoid misdiagnosis.
Keywords: Attention deficit/hyperactivity disorder, Prevalence, Methodology, Italy
Background
The exact time of onset for individual cases in psychiatry is
often not known, and prevalence estimates on a given
period are used as a substitute for identifying the proportion
of cases of a particular disorder in a defined population [1].
Several factors can influence observed prevalence rates
as the diagnostic criteria, the setting, the population stud-
ied, the type and severity of the disorder, and the comor-
bidities. Since measures of prevalence are also helpful in
assessing health care needs and in planning health care
services [2], estimates should be as accurate as possible.
This is an issue especially in mental health care, where the
risk of misdiagnosis and of false positives is a significant
problem affecting appropriate and effective interventions,
increasing the risk of medicalization and overuse of drug
treatments, and creating stigma and discrimination [3, 4],
as the worldwide debate also on attention deficit hyper-
activity disorder (ADHD) confirms [5].
To date, ADHD is considered the most common, and
most studied, developmental age disorder, even though
basic information, such as the most appropriate case
definition for estimating its prevalence rate, remains an
open issue and leaves room for significant, debates in
scientific literature [6, 7]. The reported range in preva-
lence is very wide (from 0.2 to 34.5%), and heterogeneity
in the methodological approaches used contributes to
these differences [8–12]. This is similar to the situation
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described for all child and mental health problems
worldwide [13], supporting difficulties, greater in psych-
iatry than physical medicine, in discriminating disor-
dered and non-disordered conditions [14, 15]. The 5%
increase in children diagnosed as having ADHD re-
ported in the US in recent years also suggests the need
for valid tools to support diagnosis in practice [16].
ADHD is recognized as a difficult diagnosis to make ac-
curately, not only because of the many comorbid condi-
tions, but also for the low specificity of the core symptoms:
the list of disorders or conditions that can make a child ap-
pear restless or distractible is almost endless. Making a
proper diagnosis thus requires a detailed evaluation of de-
velopment, educational demands, and what is expected of
the child in a given circumstance and at a given time, as
well as symptomatology, impairment, and risk [17, 18].
Although it is widely recognized that several ADHD
symptoms, as investigated by symptom surveys or inter-
views, may occur as manifestations of other medical (i.e.
hypoglycemia or sensory processing disorders) and psychi-
atric (i.e. mood, anxiety or autism spectrum disorders) dis-
orders, few published studies have directly examined the
rate and type of psychiatric and medical disorders in those
previously identified as ADHD positive by teacher or parent
ratings [19]. All psychiatric diagnoses are mainly
clinical-based, and both subjectivity and cultural factors
affect the evaluation of symptom severity (significant dis-
tress) and impairment (in social, academic or occupational
functioning) in the disorder [20, 21]. Furthermore, subjects
defined as having ADHD according to symptom
survey-based evaluations may not truly be suffering from
ADHD because they may meet only one of the five
DSM-IV-TR criteria (criteria A) needed to reach a diagnosis
of ADHD, and a clinical evaluation is necessary to assess
the other four criteria [22]. The risk of “misdiagnosing nor-
mality” in psychiatry is high, in particular when
symptom-based criteria for disorders, as in the DSM, are
applied using symptom checklists, in particular in popula-
tion settings and by non-medical-health professionals [14].
In such a context the goal of this study was to evaluate
certain factors that can affect the prevalence of ADHD
in reported studies and, consequently, the observed vari-
ability, in particular in overall pooled estimates. We ana-
lyzed the methodological approach used, and the
implications in practice, of Italian ADHD studies.
Methods
The research was approved by the Institutional Review
Board of the Istituto di Ricerche Farmacologiche Mario
Negri IRCCS.
Search strategy and selection criteria
We searched the Medline, Embase, and PsycINFO data-
bases for articles written in English and published before
January 2018 using the following Medical Subject Head-
ings and free text terms: “ADHD”, “ADD”, “attention
deficit”, “attention deficit hyperactivity disorder”, “hyper-
kinetic disorder”, “epidemiology”, “prevalence”, “survey”,
“child*”, and “adolesc*”. Studies with an Italian affiliation
and point prevalence estimates of ADHD in Italy were
extracted. Non indexed journals were searched for in the
Google Scholar search engine by using keywords to
identify potentially eligible studies. Articles written in
Italian were also considered. Additionally, the reference
lists of all eligible articles were scanned, as well as key
Italian journals and websites, to identify additional,
potentially relevant papers. Studies considered eligible
were those that used the diagnostic criteria or survey
instruments based on DSM-III, DSM-III-R, DSM-IV,
DSM-5, or ICD-10, with samples from community,
school, or clinically referred populations. We included
studies with participants aged < 18 years.
Data extraction and quality assessment
After removing duplicates, the two authors screened the
titles and abstracts for adherence to eligibility criteria. In
cases of uncertainty concerning eligibility, the records
were discussed until a consensus was achieved. For stud-
ies deemed suitable, we obtained the full text for data
extraction. References of suitable studies were searched
to recover any relevant articles.
Data were extracted by the authors and involved gen-
eral publication information, demographic variables of
the population sample, year of sampling, setting, frame
procedure, region and city, screening and diagnostic in-
struments used to define a case as ADHD, informant,
and whether a clinical impairment evaluation was per-
formed. The authors independently assessed each Italian
study for methodological quality. The included articles
were assessed by using a modified tool developed by
Hoy et al. [23] for assessing risk of bias in prevalence
studies that includes eight questions. These were: 1) was
the study’s target population a close representation of
the national population in relation to relevant variables?;
2) was the sampling frame a true or close representation
of the target population?; 3) was some form of random
selection used to select the sample?; 4) was the likeli-
hood of non response bias minimal?; 5) were data col-
lected directly from the subjects?; 6) was the study
instrument that measured the parameter of interest
shown to have validity and reliability?; 7) was the same
mode of data collection used for all subjects?; 8) were
the numerator(s) and denominator(s) for the parameter
of interest appropriate? A study was considered to have
a high overall risk of bias if ≤3 criteria were met, moder-
ate risk of bias if 4 or 5 criteria were met, and low risk
of bias if 6 to 8 criteria were met.
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Statistical analysis
For each retrieved study an assessment of inclusion, exclu-
sion, and quality was performed independently by the two
authors, and the inter-reviewer reliability was measured
using Cohen’s Kappa statistics. Study data were analysed
using Stata version 11.1 (Stata Corp, College Station, TX).
Because of the differences in study sample sizes, SEs of
the prevalence estimates from each study were calculated
based on the exact binomial likelihood. Summary effect
estimates of prevalence were calculated by using a random
effects meta-regression model because there was a clear
heterogeneity between the studies tested using the I2 stat-
istic [24]. The study factors that might be related to preva-
lence estimate were first tested individually in a univariate
analysis and then simultaneously in a multiple
meta-regression model via likelihood ratio test conducted
with R, using the ‘metafor’ package [25]. Study factors in-
cluded: sample size, sampling frame, informant, quality of
the study, geographical location, and diagnostic criteria.
Studies were grouped according to considered factors, and
the estimates were then pooled. We used the z test of 2
proportions to examine differences in prevalence esti-
mates of studies by factors considered. Five studies re-
ported prevalence estimates from different types of
informants. These studies were included in univariate and
multiple meta-regression analyses and in the overall
pooled results for each prevalence estimate.
Results
Our search yielded 199 citations, 5 of which were dupli-
cates (Fig. 1). After removal of unsuitable and ineligible
studies, and the addition of 9 papers retrieved from the
bibliographies of identified studies or grey literature, we
had a total of 15 unique Italian studies for quality assess-
ment and meta-analysis [26–40]. Included studies con-
tributed 22 estimates of prevalence in 67,838 subjects,
5–17 years old, over a 30-year period (Table 1). Male
sample was reported in 12 studies and lay within the
range 45–55%. Both reviewers fully agreed on the choice
of the pertinent studies (weighted K = 1). Studies meet-
ing inclusion criteria were conducted in 9 of 20 Italian
regions (45%) that cover 53% of the Italian 5–17 year
old population. However, 7 studies (47%) were con-
ducted in the North of the country. Among the 9 studies
(60%) reporting the year of sampling the time period be-
tween the data collection and the publication ranged
from 1 to 11 years (average 4). A majority of the studies
was conducted in school populations (n = 12), while the
rest were performed in clinical settings (2 in child and
adolescent neuropsychiatric services and 1 in family
paediatrician practices), using a whole population ap-
proach. Three of the school-based studies also involved
child and adolescent neuropsychiatric services in the
clinical confirmation of suspect ADHD. Overall, the
methods used in the studies were rating scales, question-
naires, interviews, or other clinical tools based mainly
on DSM-IV criteria (11 studies), while the remaining
were conducted according to DSM-III-R (2 studies),
DSM-III (1 study) and ICD-10 (1 study) criteria. The in-
formants in the studies were teachers in 11 cases, pa-
tients in 1, and parents in 3; 2 studies included both
teachers and parents.
A good agreement between reviewers on the evaluation
of the quality of the studies was found (weighted K =
0.61). No studies met all 8 criteria, although 93% had a
low, or moderate, risk of bias. The majority of studies
rated poorly for the representativeness of sample (87%).
The overall, pooled prevalence of ADHD, including all
reported prevalence estimates (n = 22), was 4.3% (95%
confidence interval [CI]:3.1 to 5.7), with a wide inter-study
range of 1.1 to 16.7% (Table 1). The prevalence estimate
of ADHD was, on average, 0.5% lower including, in the
overall pooled analysis, only the lowest estimate of each
study (3.8%, CI 2.6–5.1). In only one study of low quality
the prevalence estimate of ADHD was lower for males
than female [38], while in all other studies the rate for
boys was 1.2–7.6 higher than for girls.
The included studies used different algorithms to esti-
mate the number of children and adolescents with
ADHD. To examine the impact of these different assess-
ment procedures, separate prevalence estimates were
calculated for each specific algorithm used. The majority
of studies defined ADHD based on symptom ratings by
teachers alone (8 studies). Only 2 studies required an in-
dividual to meet symptom criteria based on both parent
and teacher ratings, using the “AND rule” algorithm that
codes as positive only if both rates agree. Finally, 6 of 15
studies (40%) used a best estimate diagnostic algorithm
in which a clinical evaluation was performed at the end
of the assessment to obtain an ADHD diagnosis based
on standard classification criteria (4 based on DSM-IV, 1
on DSM-III-R, 1 on ICD-10, and no study on DSM-5).
Four of these 6 studies assessed a population sample and
2 a population of clinically referred subjects.
Within the univariate models, prevalence estimates for
ADHD were, on average, 1.7% lower when DSM-IV cri-
teria were used than when other criteria were used
(Table 2). One study was conducted in the North,
Centre, and South of Italy and prevalence estimates for
ADHD were, on average, 2.2% lower compared to the
North, and close to those of other geographical loca-
tions. On average, similar ADHD prevalence estimates
were obtained when the informant was the clinician or
both the parent and teacher (AND rule), whereas esti-
mates were 5.1% higher when based on teacher ratings,
1% higher when based on parental reports, and 15%
higher when based on child interviews. There was a sig-
nificant increase in prevalence estimates when the
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school setting was compared with that of the popula-
tion (at school estimates were, on average 3.9%
higher). Prevalence estimates were, on average, 2.8%
lower when study sample sizes were > 1000 partici-
pants, and 1.5% higher when the quality of the study
was low or moderate (RoB score ≤ 5). Prevalence esti-
mates were, on average, slightly lower in studies pub-
lished before 2006.
According to both the clinical and methodological di-
versity of the retrieved studies, all univariate analyses re-
vealed that all considered covariates were significantly
associated with heterogeneity of prevalence estimates.
After entering all study factors into a multivariate
meta-regression, only teacher and child case definition
remained significant (Table 2).
Discussion
Performing a clinical assessment to make a diagnosis in
mental health care is necessary to define whether a sub-
ject suffers from a psychiatric disorder or not. In our
opinion, therefore, selecting an appropriate case defin-
ition that is supported by a clinician-based diagnosis is a
critical step to estimating the real prevalence rate of
ADHD.
Fig. 1 Flow diagram of Italian study retrieval and selectiongmx
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This opinion is not entirely new: 20 years ago, Swan-
son et al. [6] clearly wrote that an ADHD diagnosis
should be based on clinical history since this allows one
to define “the combination of inattentive, hyperactive,
and impulsive behaviour as a disorder when these be-
haviours are severe, developmentally inappropriate, and
impair function at home and school”. They continued
on to say that “rating scales, with the specific ADHD
symptoms, have been developed and provide a system-
atic approach for documenting clinical history, but
these are commonly compromised by rater-specific ef-
fects and thus should be confirmed by interview”. This
may be the main factor explaining the wide variation in
prevalence estimates reported by the numerous individ-
ual studies and meta-analyses. Although documented,
this study limitation is often ignored and thus increases
the controversy over whether ADHD is overdiagnosed
or underdiagnosed and the true prevalence rate of the
disorder. The appraisal we performed of the
meta-analyses confirms the weakness of the reported
overall ADHD prevalence rates. Once again, also in our
sample, the observed overlap of studies analysed in the
meta-analyses seems unnecessary and may reflect a
waste of efforts and an inefficiency in the process of
summarizing evidence [41].
We performed a systematic evaluation of the rate of
ADHD children and adolescents in Italy with the overall
aim to distinguish studies estimating ADHD prevalence
based only on symptom-surveys from studies providing
a clinically comprehensive evaluation. We also aimed to
provide an overall ADHD estimate, as done in previous
reviews. The first rate we computed was the overall Ital-
ian prevalence of ADHD, found considering all types of
samples with different case definition methodologies. As
expected, considering Italy’s ADHD history – character-
ized by a predominantly psychodynamic-psychoanalytic
approach [42] – the overall prevalence rate of 2.9%, ran-
ging from 1.1 to 16.7% is lower than the worldwide esti-
mate of 5.29% [43]. Our rate and/or range are similar to
those that emerged from older review studies [44–47],
while they differ more from those of the most recent
studies [8, 9, 11, 12, 43, 48, 49]. These data lead to sig-
nificant concern that there is inconsistent, wide variabil-
ity, not only between the rates found in the original
studies, but also between the findings of the reviews,
suggesting the need to consider which frame, diagnosis
Table 2 Association between study factors and ADHD estimates
Study factors Univariate analyses Multivariate analyses
Estimated prevalence
difference %
95% CI P Estimated prevalence
difference %
95% CI P
Min Max Min Max
Diagnostic criteria (DSM-IV as reference)
Other criteria 1.65 1.23 2.07 < 0.0001 1.21 -11.53 9.11 0.7944
Geographical location (North, Center and South
as reference)
Northern Italy 2.17 1.53 2.81 < 0.0001 −1.39 -14.42 11.65 0.8123
Central Italy −0.46 −1.15 0.23 0.1772 −8.91 -21.66 3.83 0.1454
Southern Italy 0.58 −0.11 1.27 0.1134 −5.92 -18.35 6.52 0.3045
Case definition (clinician as reference)
AND rule −0.12 −0.56 0.32 0.6161 −0.64 -12.21 10.93 0.9013
Parent 0.96 0.32 1.60 0.0003 2.09 −9.81 14.00 0.6957
Teacher 5.05 4.67 5.43 < 0.0001 12.88 4.28 21.48 0.0087
Child 15.14 12.08 18.20 < 0.0001 26.01 9.96 42.07 0.0057
Origin of sample (population as reference)
School 3.87 3.60 4.14 < 0.0001 4.41 −8.59 17.41 0.4569
Family Pediatrician Practice 0.76 0.07 1.45 0.0051 7.75 -17.67 33.16 0.5022
Quality (RoB score≥ 6 as reference)
RoB score≤ 5 1.45 1.14 1.76 < 0.0001 −5.34 -14.25 3.56 0.2038
Sample size (> 1000 participants as reference)
≤ 1000 participants 2.77 2.13 3.41 < 0.0001 4.21 −5.63 14.05 0.3528
Year of study publication (≥ 2006 as reference)
< 2006 −0.03 −0.37 0.31 0.8688 −0.04 −9.62 9.55 0.9932
Intercept 15.44 −0.89 31.77 0.0609
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criteria, and instruments the estimated and reported
ADHD prevalence rates refer. According to other au-
thors [6, 50], the prevalence of ADHD symptoms and
the prevalence of ADHD diagnosis are rates that should
be carefully differentiated from each other because they
reflect two different subject populations, and they are
also populations with different health care needs.
The first population (ADHD symptom rate) is the
number of subjects presenting ADHD symptoms who
could have an ADHD disorder or another psychiatric or
medical disorder with similar clinical manifestations.
This population is often recognized through symptom
surveys compiled by parents or teachers, and needs a
clinical evaluation to confirm whether ADHD is actually
present. This population therefore represents the num-
ber of children and adolescents with behavioral symp-
toms of ADHD who need a specific evaluation by a
specialist service/clinician.
From our findings, this population in Italy, calculated
from studies with data rates based on only
symptom-surveys, consists of about 439,000 subjects (5.9%,
range: 1.4–16.7) among children and adolescents aged 5 to
17 years of the Italian paediatric population. This is, from a
health care point of view, the population of subjects who
need a psychiatric evaluation. This rate, based on
symptom-surveys, differs from that found with the same
methodological approach in Thomas and colleagues’ review
(5.9 vs. 13%) [12], as well as from those based on parent
(2.5%, range: 2.4–2.5%) and teacher ratings (6.7%, range:
4.5–10.8%), which are both lower compared to similar, pre-
vious analyses on the literature [8, 9, 47, 49]. This result
could also be expected, however, taking into consideration
that cultural factors, such as higher symptom tolerance,
may modulate the interpretation of the child’s behaviours
in parent and teacher evaluations [42, 51].
The second rate, the prevalence of ADHD diagnosis,
is, according to us, the real rate of ADHD prevalence
and refers to the number of patients presenting ADHD
symptoms who have an ADHD diagnosis confirmed by a
clinical evaluation. This population, similarly to the pre-
vious one, can be recognized through symptom surveys
compiled by parents or teachers, but has an ADHD
diagnosis and evaluation that confirm the presence of
ADHD. This second population represents the number
of children and adolescents with an ADHD diagnosis
who need a specific treatment for ADHD.
From our findings, in Italy this population (ADHD diag-
nosis), calculated from studies including only patients with
an ADHD diagnosis confirmed by clinical evaluation, con-
sists of about 105,000 subjects (1.4%, range: 1.1–3.1)
among the Italian paediatric population aged 5 to 17 years.
From a health care point of view, this is the population of
patients who need treatment. In line with previous com-
ments, only a few review studies calculated the prevalence
of ADHD diagnosis separately from the overall rate. It is
even more important to keep in mind the distinction
between diagnostic procedures if we consider that our
findings (1.4%, range: 1.1–3.1) differ from those of
Willcutt [9] (5.9%, range: 4.6–7.5) even when the better
estimate diagnostic procedure is employed.
Finally, although we found similar rates between the
overall ADHD prevalence (2.9%; range: 1.1–16.7) and the
ADHD diagnosis prevalence (1.4%, range: 1.1–3.1), when
diagnostic case definition based on clinical evaluation is
used, comparisons of the range rates suggest that the
differences between these homogenous types of studies
are small, and, thus, in our opinion, more accurate.
Results should be interpreted in the context of two
main limitations. First, the number of studies included is
small and the methodological approach is heterogeneous
so the findings that emerged may not be similar to those
of other contexts or countries. Second, although this is
the first study analyzing the overall ADHD prevalence in
Italy, all data originate from a single country. This may
affect the comparability of the reported findings and the
generalization of the results to a worldwide scenario
would therefore be inappropriate.
Conclusions
Epidemiological studies concerning ADHD need more
efforts to identify the cases, to assess the prevalence, and
to use administrative databases as provided by the
American Agency for Healthcare Research and Quality
(AHRQ) [52]. In our opinion, considering only subjects
with an ADHD diagnosis performed and confirmed by
full clinical assessment (according to European and
international guidelines) as a case definition for epi-
demiological ADHD studies would reduce the wide vari-
ability in ADHD estimates previously described. Above
all, it would represent the real rate of subjects suffering
from ADHD disorder and would avoid misdiagnosis.
Mental health is certainly a public health issue, and
many disorders arise in childhood. To support the promo-
tion of mental wellbeing and the primary prevention of
psychiatric condition [53] knowledge of the true dimen-
sion of the problem – in this case the ADHD prevalence
– is fundamental for planning and achieving appropriate
treatments and interventions.
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